Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lionel Hebbard

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Biomedicines|November 27, 2021
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular CarcinomaEun Jin Sun, Miriam Wankell, Pranavan Palamuthusingam, et al.
Cancer Letters|April 20, 2016
Overcoming treatment resistance in cancer: Current understanding and tacticsGuang Wu, George Wilson, Jacob George, et al.
Discovery Medicine|November 13, 2015
Oct4 is a reliable marker of liver tumor propagating cells in hepatocellular carcinomaGuang Wu, George Wilson, Gang Zhou, et al.
Heart, Lung & Circulation|May 11, 2026
Quantification of Sarcopenia using Chest Computed Tomography of the Pectoralis Major Muscle as a Prognostic Tool for Cardiac Surgery OutcomesPouya Nezafati, Pankaj Saxena, Jai Raman, et al.
Current Pharmaceutical Design|February 12, 2013
Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLDLucia Carulli, Mauro Maurantonio, Lionel Hebbard, et al.
Briefings in Bioinformatics|December 17, 2022
Recent advances in cancer fusion transcript detectionRyley Dorney, Bijay P Dhungel, John E J Rasko, et al.
Animal Models and Experimental Medicine|February 27, 2026
Molecular characterization of the A52 murine hepatocellular carcinoma cell lineRhys Gillman, Eun Jin Sun, Miriam Wankell, et al.
Cells|June 20, 2019
The Role of Micronutrients in the Infection and Subsequent Response to Hepatitis C VirusSunil Gupta, Scott A Read, Nicholas A Shackel, et al.
Advanced Drug Delivery Reviews|April 9, 2018
Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancersGang Zhou, Olivier Latchoumanin, Lionel Hebbard, et al.
Cancer Letters|January 17, 2017
Recent clinical trials utilizing chimeric antigen receptor T cells therapies against solid tumorsShuanglin Han, Olivier Latchoumanin, Guang Wu, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Biomedicines|November 27, 2021
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular CarcinomaEun Jin Sun, Miriam Wankell, Pranavan Palamuthusingam, et al.
Cancer Letters|April 20, 2016
Overcoming treatment resistance in cancer: Current understanding and tacticsGuang Wu, George Wilson, Jacob George, et al.
Discovery Medicine|November 13, 2015
Oct4 is a reliable marker of liver tumor propagating cells in hepatocellular carcinomaGuang Wu, George Wilson, Gang Zhou, et al.
Heart, Lung & Circulation|May 11, 2026
Quantification of Sarcopenia using Chest Computed Tomography of the Pectoralis Major Muscle as a Prognostic Tool for Cardiac Surgery OutcomesPouya Nezafati, Pankaj Saxena, Jai Raman, et al.
Current Pharmaceutical Design|February 12, 2013
Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLDLucia Carulli, Mauro Maurantonio, Lionel Hebbard, et al.
Briefings in Bioinformatics|December 17, 2022
Recent advances in cancer fusion transcript detectionRyley Dorney, Bijay P Dhungel, John E J Rasko, et al.
Animal Models and Experimental Medicine|February 27, 2026
Molecular characterization of the A52 murine hepatocellular carcinoma cell lineRhys Gillman, Eun Jin Sun, Miriam Wankell, et al.
Cells|June 20, 2019
The Role of Micronutrients in the Infection and Subsequent Response to Hepatitis C VirusSunil Gupta, Scott A Read, Nicholas A Shackel, et al.
Advanced Drug Delivery Reviews|April 9, 2018
Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancersGang Zhou, Olivier Latchoumanin, Lionel Hebbard, et al.
Cancer Letters|January 17, 2017
Recent clinical trials utilizing chimeric antigen receptor T cells therapies against solid tumorsShuanglin Han, Olivier Latchoumanin, Guang Wu, et al.
Pageof 5